Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Chugai Pharmaceutical Co., Ltd.

Market Cap 12,379B 76.58B 67.02B 61.9B 57.84B 108B 7,253B 109B 731B 285B 3,562B 288B 281B P/E 2026 *
24.3x
P/E 2027 * 20.9x
Enterprise Value 11,457B 70.87B 62.03B 57.28B 53.53B 100B 6,712B 101B 676B 264B 3,296B 266B 260B EV / Sales 2026 *
8.26x
EV / Sales 2027 * 7.3x
Free-Float
38.12%
Yield 2026 *
1.82%
Yield 2027 * 2.08%
1 day-0.37%
1 week+0.97%
Current month-4.69%
1 month-4.01%
3 months-13.04%
6 months-9.28%
Current year-8.75%
1 week 7,386
Extreme 7386
7,719
1 month 7,270
Extreme 7270
8,215
Current year 7,270
Extreme 7270
10,700
1 year 5,942
Extreme 5942
10,700
3 years 3,767
Extreme 3767
10,700
5 years 3,191
Extreme 3191
10,700
10 years 1,003.33
Extreme 1003.3333
10,700
Manager TitleAgeSince
Chief Executive Officer 63 2020-12-31
Director of Finance/CFO - 2024-03-27
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 68 1993-02-28
Director/Board Member 81 2015-02-28
Director/Board Member 77 2017-02-28
Change 5-day change 1-year change 3-year change Capi.($)
-0.37%+0.97%+4.63%+74.77% 77.05B
+0.32%-2.73%+44.49%+143.28% 980B
+1.27%-3.98%+54.41%+41.13% 550B
+6.25%+1.00%+24.13%+68.06% 382B
+0.25%-3.09%+23.33%+16.78% 316B
+0.42%-1.28%+27.89%+14.71% 272B
+1.67%-1.47%+26.76%+32.88% 268B
+2.39%+4.42%-36.96%-45.12% 199B
+2.11%-2.95%+19.14%+51.83% 182B
+0.90%-0.57%+15.09%+60.89% 154B
Average +0.74%-2.29%+20.29%+45.92% 337.94B
Weighted average by Cap. +0.53%-3.39%+30.67%+65.90%

Financials

2026 *2027 *
Net sales 1,387B 8.58B 7.51B 6.93B 6.48B 12.15B 813B 12.26B 81.86B 31.98B 399B 32.23B 31.53B 1,535B 9.5B 8.31B 7.68B 7.17B 13.44B 899B 13.57B 90.6B 35.4B 442B 35.68B 34.9B
Net income 509B 3.15B 2.75B 2.54B 2.38B 4.46B 298B 4.5B 30.03B 11.73B 146B 11.82B 11.57B 593B 3.67B 3.21B 2.97B 2.77B 5.19B 348B 5.24B 35.01B 13.68B 171B 13.79B 13.49B
Net Debt -923B -5.71B -4.99B -4.61B -4.31B -8.08B -540B -8.16B -54.45B -21.27B -265B -21.44B -20.98B -1,166B -7.21B -6.31B -5.83B -5.45B -10.21B -683B -10.31B -68.8B -26.88B -335B -27.09B -26.5B
Logo Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases such as rheumatoid arthritis, osteoporosis, knee osteoarthritis and locomotive syndrome, influenza, hemophilia and other diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. The Company operates within the domestic market and to overseas markets, including Switzerland, United Kingdom, Germany, France, China, Singapore, Korea and the United States.
Employees
5,104
Date Price Change Volume
26-06-22 7,522.00 ¥ -0.37% 1,238,100
26-06-19 7,550.00 ¥ -0.21% 3,697,700
26-06-18 7,566.00 ¥ -1.10% 1,954,000
26-06-17 7,650.00 ¥ +1.69% 1,745,000
26-06-16 7,523.00 ¥ +1.28% 2,083,200
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
7,522.00JPY
Average target price
9,973.33JPY
Spread / Average Target
+32.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4519 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!